SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001559053-13-000010
Filing Date
2013-11-12
Accepted
2013-11-12 16:13:32
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q prta2013q310q.htm 10-Q 781917
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - SECTION 302 prta2013q310-qxex311.htm EX-31.1 14455
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - SECTION 302 prta2013q310-qxex312.htm EX-31.2 14577
4 CERT. OF PRINCIPAL EXECUTIVE OFFICER & PRINCIPAL FINANCIAL OFFICER- SECTION 906 prta2013q310-qxex321.htm EX-32.1 14892
  Complete submission text file 0001559053-13-000010.txt   3869071

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT prta-20130930.xml EX-101.INS 484473
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prta-20130930.xsd EX-101.SCH 26636
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prta-20130930_cal.xml EX-101.CAL 42879
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prta-20130930_def.xml EX-101.DEF 124577
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prta-20130930_lab.xml EX-101.LAB 330053
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prta-20130930_pre.xml EX-101.PRE 203316
Mailing Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1 650-615-2119
Prothena Corp plc (Filer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35676 | Film No.: 131210312
SIC: 2834 Pharmaceutical Preparations